Application of "omics" to prion biomarker discovery

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Booth, Stephanie A ^a   Huzarewich, Rhiannon L C H ^a   Siemens, Christine G ^a,b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PRION PROTEIN; BIOLOGICAL MARKER; NERVE PROTEIN;

BODY FLUID; BRAIN TISSUE; CEREBROSPINAL FLUID; DISEASE COURSE; DISEASE MARKER; GENOMICS; IMMUNOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRION; PRION DISEASE; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; BLOOD; GENE EXPRESSION PROFILING; HUMAN; METHODOLOGY;

BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; HUMANS; NERVE TISSUE PROTEINS; PRION DISEASES; PROTEOMICS;

EID: 77951683575     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/613504     Document Type: Review

References (91)

1. Prusiner S. B., Prions Proceedings of the National Academy of Sciences of the United States of America 1998 95 23 13363 13383
2. Ladogana A., Puopolo M., Croes E. A., Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada Neurology 2005 64 9 1586 1591 (Pubitemid 40617696)
3. Brown P., Brandel J.-P., Preese M., Sato T., Iatrogenic Creutzfeldt-Jakob disease: the waning of an era Neurology 2006 67 3 389 393 (Pubitemid 44214958)
4. Llewelyn C. A., Hewitt P. E., Knight R. S. G., Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion The Lancet 2004 363 9407 417 421 (Pubitemid 38210057)
5. Bishop M., Hart P., Aitchison L., Predicting susceptibility and incubation time of human-to-human transmission of vCJD The Lancet Neurology 2006 5 5 393 398
6. Belay E. D., Maddox R. A., Williams E. S., Miller M. W., Gambetti P., Schonberger L. B., Chronic wasting disease and potential transmission to humans Emerging Infectious Diseases 2004 10 6 977 984 (Pubitemid 38697686)
7. Raymond G. J., Bossers A., Raymond L. D., Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease The EMBO Journal 2000 19 17 4425 4430
8. Gambetti P., Dong Z., Yuan J., A novel human disease with abnormal prion protein sensitive to protease Annals of Neurology 2008 63 6 697 708 (Pubitemid 351945529)
9. Blennow K., Johansson A., Zetterberg H., Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease International Journal of Molecular Medicine 2005 16 6 1147 1149
10. Sanchez-Juan P., Green A., Ladogana A., CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease Neurology 2006 67 4 637 643 (Pubitemid 44273611)
11. Green A. J. E., Thompson E. J., Stewart G. E., Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease Journal of Neurology Neurosurgery and Psychiatry 2001 70 6 744 748
12. Ness S. A., Microarray analysis: basic strategies for successful experiments Molecular Biotechnology 2007 36 3 205 219 (Pubitemid 350135912)
13. Mortazavi A., Williams B. A., McCue K., Schaeffer L., Wold B., Mapping and quantifying mammalian transcriptomes by RNA-Seq Nature Methods 2008 5 7 621 628 (Pubitemid 351911867)
14. Wilhelm B. T., Marguerat S., Watt S., Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide resolution Nature 2008 453 7199 1239 1243 (Pubitemid 351913597)
15. Rosenkranz R., Borodina T., Lehrach H., Himmelbauer H., Characterizing the mouse ES cell transcriptome with Illumina sequencing Genomics 2008 92 4 187 194
16. Bushati N., Cohen S. M., MicroRNAs in neurodegeneration Current Opinion in Neurobiology 2008 18 3 292 296
17. Ingolia N. T., Ghaemmaghami S., Newman J. R. S., Weissman J. S., Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling Science 2009 324 5924 218 223
18. Xiang W., Windl O., Westner I. M., Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease Annals of Neurology 2005 58 2 242 257 (Pubitemid 41098882)
19. Baker C. A., Manuelidis L., Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease Proceedings of the National Academy of Sciences of the United States of America 2003 100 2 675 679 (Pubitemid 36126111)
20. Sorensen G., Medina S., Parchaliuk D., Phillipson C., Robertson C., Booth S. A., Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes BMC Genomics 2008 9, article 114
21. Booth S., Bowman C., Baumgartner R., Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection Journal of General Virology 2004 85 11 3459 3471
22. Xiang W., Windl O., Wnsch G., Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology Journal of Virology 2004 78 20 11051 11060
23. Riemer C., Neidhold S., Burwinkel M., Gene expression profiling of scrapie-infected brain tissue Biochemical and Biophysical Research Communications 2004 323 2 556 564
24. Sawiris G. P., Becker K. G., Elliott E. J., Moulden R., Rohwer R. G., Molecular analysis of bovine spongiform encephalopathy infection by cDNA arrays Journal of General Virology 2007 88 4 1356 1362
25. Skinner P. J., Abbassi H., Chesebro B., Race R. E., Reilly C., Haase A. T., Gene expression alterations in brains of mice infected with three strains of scrapie BMC Genomics 2006 7, article 114
26. Tang Y., Xiang W., Hawkins S. A. C., Kretzschmar H. A., Windl O., Transcriptional changes in the brains of cattle orally infected with the bovine spongiform encephalopathy agent precede detection of infectivity Journal of Virology 2009 83 18 9464 9473
27. Cosseddu G. M., Androletti O., Maestrale C., Gene expression profiling on sheep brain reveals differential transcripts in scrapie-affected/not-affected animals Brain Research 2007 1142 1 217 222
28. Dandoy-Dron F., Guillo F., Benboudjema L., Gene expression of scrapie: cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts Journal of Biological Chemistry 1998 273 13 7691 7697
29. Rite I., Argelles S., Venero J. L., Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration Journal of Neuroscience Research 2007 85 16 3607 3618
30. Brown A. R., Webb J., Rebus S., Williams A., Fazakerley J. K., Identification of up-regulated genes by array analysis in scrapie-infected mouse brains Neuropathology and Applied Neurobiology 2004 30 5 555 567
31. Blalock E. M., Geddes J. W., Chen K. C., Porter N. M., Markesbery W. R., Landfield P. W., Incipient Alzheimers disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses Proceedings of the National Academy of Sciences of the United States of America 2004 101 7 2173 2178
32. Wu Z.-L., Ciallella J. R., Flood D. G., OKane T. M., Bozyczko-Coyne D., Savage M. J., Comparative analysis of cortical gene expression in mouse models of Alzheimers disease Neurobiology of Aging 2006 27 3 377 386
33. Wilson K. E., Marouga R., Prime J. E., Comparative proteomic analysis using samples obtained with laser microdissection and saturation dye labelling Proteomics 2005 5 15 3851 3858
34. Zhang R., Barker L., Pinchev D., Mining biomarkers in human sera using proteomic tools Proteomics 2004 4 1 244 256
35. Dufek M., Hamanov M., Lokaj J., Serum inflammatory biomarkers in Parkinsons disease Parkinsonism and Related Disorders 2009 15 4 318 320
36. Miele G., Seeger H., Marino D., Urinary 1-antichymotrypsin: a biomarker of prion infection PLoS ONE 2008 3 12, article e3870
37. Simon S. L. R., Lamoureux L., Plews M., The identification of disease-induced biomarkers in the urine of BSE infected cattle Proteome Science 2008 6, article 23
38. Sihlbom C., Kanmert I., von Bahr H., Davidsson P., Evaluation of the combination of bead technology with SELDI-TOF-MS and 2-D DIGE for detection of plasma proteins Journal of Proteome Research 2008 7 9 4191 4198
39. Sasaki K., Doh-ura K., Ironside J. W., Iwaki T., Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies Acta Neuropathologica 2002 103 3 199 208
40. Goldknopf I. L., Sheta E. A., Bryson J., Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinsons disease Biochemical and Biophysical Research Communications 2006 342 4 1034 1039
41. Hye A., Lynham S., Thambisetty M., Proteome-based plasma biomarkers for Alzheimers disease Brain 2006 129 11 3042 3050
42. Guillaume E., Zimmermann C., Burkhard P. R., Hochstrasser D. F., Sanchez J.-C., A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease Proteomics 2003 3 8 1495 1499
43. Brechlin P., Jahn O., Steinacker P., Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease Proteomics 2008 8 20 4357 4366
44. Poon T. C. W., Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices Expert Review of Proteomics 2007 4 1 51 65
45. Winkler W., Zellner M., Diestinger M., Biological variation of the platelet proteome in the elderly population and its implication for biomarker research Molecular and Cellular Proteomics 2008 7 1 193 203
46. Ross P. L., Huang Y. N., Marchese J. N., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents Molecular and Cellular Proteomics 2004 3 12 1154 1169
47. Ong S. E., Blagoev B., Kratchmarova I., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics Molecular and Cellular Proteomics 2002 1 5 376 386
48. Cancilla M. T., Penn S. G., Lebrilla C. B., Alkaline degradation of oligosaccharides coupled with matrix-assisted laser desorption/ionization Fourier transform mass spectrometry: a method for sequencing oligosaccharides Analytical Chemistry 1998 70 4 663 672
49. Chalmers M. J., Mackay C. L., Hendrickson C. L., Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease Analytical Chemistry 2005 77 22 7163 7171
50. Ray S., Britschgi M., Herbert C., Classification and prediction of clinical Alzheimers diagnosis based on plasma signaling proteins Nature Medicine 2007 13 11 1359 1362
51. Khaniya B., Almeida L., Basu U., Microarray analysis of differentially expressed genes from Peyers patches of cattle orally challenged with bovine spongiform encephalopathy Journal of Toxicology and Environmental Health. Part A 2009 72 17-18 1008 1013
52. Austb L., Kampmann A., Mller-Ladner U., Neumann E., Olsaker I., Skretting G., Identification of differentially expressed genes in ileal Peyers patch of scrapie-infected sheep using RNA arbitrarily primed PCR BMC Veterinary Research 2008 4, article 12
53. Brown K. L., Stewart K., Ritchie D. L., Scrapie replication in lymphoid tissues depends on prion protein- expressing follicular dendritic cells Nature Medicine 1999 5 11 1308 1312
54. Ltscher M., Recher M., Hunziker L., Klein M. A., Immunologically induced, complement-dependent up-regulation of the prion protein in the mouse spleen: follicular dendritic cells versus capsule and trabeculae Journal of Immunology 2003 170 12 6040 6047
55. Mabbott N. A., Bruce M. E., The immunobiology of TSE diseases Journal of General Virology 2001 82 10 2307 2318
56. Mabbott N. A., Mackay F., Minns F., Bruce M. E., Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie Nature Medicine 2000 6 7 719 720
57. Mabbott N. A., Young J., McConnell I., Bruce M. E., Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility Journal of Virology 2003 77 12 6845 6854
58. Aucouturier P., Carnaud C., The immune system and prion diseases: a relationship of complicity and blindness Journal of Leukocyte Biology 2002 72 6 1075 1083
59. Guillerme-Bosselut F., Forestier L., Jayat-Vignoles C., Glycosylation-related gene expression profiling in the brain and spleen of scrapie-affected mouse Glycobiology 2009 19 8 879 889
60. Sasaki K., Doh-ura K., Ironside J. W., Mabbott N., Iwaki T., Clusterin expression in follicular dendritic cells associated with prion protein accumulation Journal of Pathology 2006 209 4 484 491 (Pubitemid 44194563)
61. Glatzel M., Abela E., Maissen M., Aguzzi A., Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease The New England Journal of Medicine 2003 349 19 1812 1820 (Pubitemid 37362957)
62. Piubelli C., Fiorini M., Zanusso G., Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping Proteomics 2006 6 supplement 1 S256 S261
63. Cepek L., Brechlin P., Steinacker P., Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Dementia and Geriatric Cognitive Disorders 2006 23 1 22 28
64. Sanchez J.-C., Guillaume E., Lescuyer P., Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease Proteomics 2004 4 8 2229 2233
65. Carrette O., Demalte I., Scherl A., A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimers disease Proteomics 2003 3 8 1486 1494 (Pubitemid 37048074)
66. Gao W.-M., Chadha M. S., Berger R. P., A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury Journal of Neurotrauma 2007 24 1 43 53 (Pubitemid 46214411)
67. Pucci L., Triscornia S., Lucchesi D., Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients Clinical Chemistry 2007 53 3 480 488 (Pubitemid 46447945)
68. Herbst A., McIlwain S., Schmidt J. J., Aiken J. M., Page C. D., Li L., Prion disease diagnosis by proteomic profiling Journal of Proteome Research 2009 8 2 1030 1036
69. Martin T. C., Moecks J., Belooussov A., Classification of signatures of Bovine Spongiform Encephalopathy in serum using infrared spectroscopy Analyst 2004 129 10 897 901 (Pubitemid 39434024)
70. Otto M., Wiltfang J., Schtz E., Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study British Medical Journal 1998 316 7131 577 582 (Pubitemid 28120987)
71. Miele G., Manson J., Clinton M., A novel erythroid-specific marker of transmissible spongiform encephalopathies Nature Medicine 2001 7 3 361 363 (Pubitemid 32224354)
72. Brown A. R., Blanco A. R. A., Miele G., Differential expression of erythroid genes in prion disease Biochemical and Biophysical Research Communications 2007 364 2 366 371
73. Li X., Gong Y., Wang Y., Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project Proteomics 2005 5 13 3423 3441
74. Ueno I., Sakai T., Yamaoka M., Yoshida R., Tsugita A., Analysis of blood plasma proteins in patients with Alzheimers disease by two-dimensional electrophoresis, sequence homology and immunodetection Electrophoresis 2000 21 9 1832 1845
75. Aucouturier P., Geissmann F., Damotte D., Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie Journal of Clinical Investigation 2001 108 5 703 708
76. Chrtien F., Le Pavec G., Vallat-Decouvelaere A.-V., Expression of excitatory amino acid transporter-1 (EAAT-1) in brain macrophages and microglia of patients with prion diseases Journal of Neuropathology and Experimental Neurology 2004 63 10 1058 1071
77. Serban A., Legname G., Hansen K., Kovaleva N., Prusiner S. B., Immunoglobulins in urine of hamsters with scrapie Journal of Biological Chemistry 2004 279 47 48817 48820
78. McHattie S., Wells G. A. H., Bee J., Edington N., Clusterin in bovine spongiform encephalopathy (BSE) Journal of Comparative Pathology 1999 121 2 159 171
79. Dalrymple A., Wild E. J., Joubert R., Proteomic profiling of plasma in Huntingtons disease reveals neuroinflammatory activation and biomarker candidates Journal of Proteome Research 2007 6 7 2833 2840
80. van Niel G., Porto-Carreiro I., Simoes S., Raposo G., Exosomes: a common pathway for a specialized function Journal of Biochemistry 2006 140 1 13 21
81. Robertson C., Booth S. A., Beniac D. R., Coulthart M. B., Booth T. F., McNicol A., Cellular prion protein is released on exosomes from activated platelets Blood 2006 107 10 3907 3911
82. Fevrier B., Vilette D., Archer F., Cells release prions in association with exosomes Proceedings of the National Academy of Sciences of the United States of America 2004 101 26 9683 9688
83. Prinz M., Helkenwalder M., Junt T., Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion Nature 2003 425 6961 957 962
84. Zhou H., Pisitkun T., Aponte A., Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury Kidney International 2006 70 10 1847 1857
85. Skog J., Wrdinger T., van Rijn S., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nature Cell Biology 2008 10 12 1470 1476
86. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function Cell 2004 116 2 281 297
87. Saba R., Goodman C. D., Huzarewich R. L. C. H., Robertson C., Booth S. A., A miRNA signature of prion induced neurodegeneration PLoS ONE 2008 3 11, article e3652
88. Lukiw W. J., Pogue A. I., Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells Journal of Inorganic Biochemistry 2007 101 9 1265 1269
89. Kim J., Inoue K., Ishii J., A microRNA feedback circuit in midbrain dopamine neurons Science 2007 317 5842 1220 1224
90. Montag J., Hitt R., Opitz L., Schulz-Schaeffer W. J., Hunsmann G., Motzkus D., Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease Molecular Neurodegeneration 2009 4 1, article 36
91. Osaki M., Takeshita F., Ochiya T., MicroRNAs as biomarkers and therapeutic drugs in human cancer Biomarkers 2008 13 7-8 658 670